blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4031569

EP4031569 - ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  24.06.2022
Database last updated on 14.06.2024
FormerThe international publication has been made
Status updated on  27.03.2021
Most recent event   Tooltip17.04.2024Amendment by applicant 
Applicant(s)For all designated states
Opsidio, LLC
P.O. Box 802
Bryn Mawr, Pennsylvania 19010 / US
[2022/30]
Inventor(s)01 / PHILLIPS, Martin
c/o Opsidio, LLC
P.O. Box 802
Bryn Mawr, Pennsylvania 19010 / US
 [2022/30]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[2022/30]
Application number, filing date20866530.716.09.2020
[2022/30]
WO2020US50973
Priority number, dateUS201962900927P16.09.2019         Original published format: US 201962900927 P
[2022/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021055408
Date:25.03.2021
Language:EN
[2021/12]
Type: A1 Application with search report 
No.:EP4031569
Date:27.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 25.03.2021 takes the place of the publication of the European patent application.
[2022/30]
Search report(s)International search report - published on:US25.03.2021
(Supplementary) European search report - dispatched on:EP18.09.2023
ClassificationIPC:C07K16/22
[2022/30]
CPC:
A61P11/06 (EP,IL,US); C07K16/24 (EP,IL,KR,US); A61P11/00 (EP,IL,US);
A61P29/00 (EP,IL,KR,US); A61P37/08 (EP,IL,US); C12N15/63 (US);
A61K2039/505 (EP,IL,KR,US); C07K2317/24 (EP,IL,KR,US); C07K2317/33 (IL,US);
C07K2317/34 (EP,IL,KR,US); C07K2317/56 (IL,US); C07K2317/565 (IL,US);
C07K2317/76 (EP,IL,KR,US); C07K2317/77 (EP,IL,KR,US); C07K2317/92 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/30]
Extension statesBA08.04.2022
ME08.04.2022
Validation statesKH08.04.2022
MA08.04.2022
MD08.04.2022
TN08.04.2022
TitleGerman:ANTIKÖRPER GEGEN STAMMZELLFAKTOR UND VERWENDUNGSVERFAHREN DAFÜR[2022/30]
English:ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF[2022/30]
French:ANTICORPS ANTI-FACTEUR DE CELLULES SOUCHES ET LEURS PROCÉDÉS D'UTILISATION[2022/30]
Entry into regional phase08.04.2022National basic fee paid 
08.04.2022Search fee paid 
08.04.2022Designation fee(s) paid 
08.04.2022Examination fee paid 
Examination procedure08.04.2022Examination requested  [2022/30]
15.04.2024Amendment by applicant (claims and/or description)
15.04.2024Date on which the examining division has become responsible
Fees paidRenewal fee
07.09.2022Renewal fee patent year 03
27.09.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]  - FONSECA WENDY ET AL, "Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease", MUCOSAL IMMUNOLOGY, New York, (20190107), vol. 12, no. Suppl. 5, doi:10.1038/s41385-018-0117-1, ISSN 1933-0219, pages 1 - 12, XP055807780 [I] 1-18 * whole document, especially pages 4,5,8 and Figs. 1, 3d and 4a-b *

DOI:   http://dx.doi.org/10.1038/s41385-018-0117-1
International search[A]US7285640  (TAKEUCHI TOSHIHIKO [US], et al) [A] 1-13 * ; abstract; claim 1 *;
 [A]US2017152315  (HANSEN HANS J [US], et al) [A] 1-13 * ; paragraph [0051] *;
 [A]  - KURAOKA, M et al., "Immunoglobulin heavy chain variable region, partial [Mus musculus]", GenBank, (20160310), Database accession no. AML31316.1, XP055807968 [A] 1-13 * ; page 2 *
 [A]  - ANANTHARAMAN, K et al., "Hypothetical protein A3G85_00225 [Elusimicrobia bacterium RIFCSPLOWO2_12_FULL_39_28", GenBank, (20160718), Database accession no. OGS00894.1 [A] 1-13 * ; page 7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.